N | T0* | T1* | |
Blood | 33 | ||
INI | 22 | 3 (2–5) | 0 (0–0.25) |
PI | 7 | 4 (2–5) | 1 (0–2) |
NNRTI | 4 | 3.5 (1.5–4.75) | 1 (0.25–1) |
Seminal plasma | 33 | ||
INI | 22 | 6 (3.75) | 0 (0–2) |
PI | 7 | 5 (4–7) | 2 (0–4) |
NNRTI | 4 | 6 (3.75–6.75) | 1 (0.25–1.75) |
N | T0* | T1* | P value | |
Blood | 33 | |||
INI | 22 | 3 (2–5) | 0 (0–0.25) | <0.001 |
PI | 7 | 4 (2–5) | 1 (0–2) | 0.051 |
NNRTI | 4 | 3.5 (1.5–4.75) | 1 (0.25–1) | 0.327 |
Seminal plasma | 33 | |||
INI | 22 | 6 (3.75–8) | 0 (0–2) | <0.001 |
PI | 7 | 5 (4–7) | 2 (0–4) | 0.051 |
NNRTI | 4 | 6 (3.75–6.75) | 1 (0.25–1.75) | 0.204 |
*Median (IQR, 25th–75th percentile).
INI, integrase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors.